Skip to content
zameds

Ephedrine

Sold as Ephedrine hydrochloride lennon, Ipesandrine, Ephedrine hydrochloride, Universal asthma nf, Ephedrine sulphate

Loading the molecular structure
C10H15NO165.23 g/mol

(1R,2S)-2-(Methylamino)-1-phenylpropan-1-ol

Drag to rotate. Structure from PubChem CID 9294.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
5
Registrations
6

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Pharmacare limited û woodmeadCancelledEphedrine hydrochloride lennon30 mg -G0537Not determinedNone
Sandoz South Africa (Pty) LtdIpesandrineNot statedG1057Not determinedNone
The Premier Pharmaceutical Co LtdCancelledEphedrine hydrochloride30 MG, 60 MGG1205, G1206Not determinedNone
Universal Pharmaceuticals (Pty) LtdUniversal asthma nfmixtureG1243Not determinedNone
Pfizer Laboratories (Pty) LtdEphedrine sulphate50 mg/mlR0252Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Ephedrine hydrochloride 30 MG - lennon

EACH TABLET CONTAINS EPHEDRINE HYDROCHLORIDE A 30 mg

30 mg -G0537CancelledNot determinedNone
Ipesandrine

5 ML EPHEDRINE HYDROCHLORIDE A 2,5 MG

Not listedG1057Old MedicineNot determinedNone
Ephedrine hydrochloride tablets 30 MG

TABLET EPHEDRINE HYDROCHLORIDE A 30 MG

30 MGTabletsG1205CancelledNot determinedNone
Ephedrine hydrochloride tablets 60 MG

TABLET EPHEDRINE HYDROCHLORIDE A 60 MG

60 MGTabletsG1206CancelledNot determinedNone
Universal asthma mixture nf

10 ML EPHEDRINE HYDROCHLORIDE A 21,6 MG

MixtureG1243Old MedicineNot determinedNone
Ephedrine sulphate injection 50 mg/ml

EACH 1 ml SOLUTION CONTAINS EPHEDRINE SULPHATE 50 mg

50 mg/mlInjectionR0252RX/5.1/252RegisteredNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S6: Ephedrine

    • except products registered in terms of the Act, not intended for export, and being oral preparations and mixtures, in combination with another pharmacologically active substance and intended for the symptomatic relief of colds and flu, containing not more than 30 milligrams of ephedrine per dose, with a maximum daily dose not exceeding 120 milligrams, subject to a maximum pack size of 360 milligrams and limited to one pack per customer; (S2)
    • except preparations and mixtures intended for application to the skin, eyes, ears and nares and containing 1 percent or less of ephedrine. (S1)

    Consolidated Schedules 06 July 2026, lines 10226 to 10235

  • S2: Ephedrine

    • contained in products registered in terms of the Act, and not intended for export,
    • oral preparations and mixtures, in combination with another pharmacologically active substance and intended for the symptomatic relief of colds and flu, containing not more than 30 milligrams of ephedrine per dose, with a maximum daily dose not exceeding 120 milligrams, subject to a maximum pack size of 360 milligrams and limited to one pack per customer; (S6)
    • except preparations and mixtures intended for application to the skin, eyes, ears and nares and containing 1 percent or less of ephedrine. (S1)

    Consolidated Schedules 06 July 2026, lines 1899 to 1907

  • S1: Ephedrine

    • preparations and mixtures intended for application to the skin, eyes, ears and nares and containing 1 percent or less of ephedrine, and not intended for export; (S6)
    • except products registered in terms of the Act, not intended for export, and being oral preparations and mixtures, in combination with another pharmacologically active substance and intended for the symptomatic relief of colds and flu, containing not more than 30 milligrams of ephedrine per dose, with a maximum daily dose not exceeding 120 milligrams, subject to a maximum pack size of 360 milligrams and limited to one pack per customer. (S2)

    Consolidated Schedules 06 July 2026, lines 410 to 419

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles